Glioblastoma Multiforme (GBM) is an aggressive brain cancer. Immunotherapy is a promising avenue of exploration for treatment of GBM. We discovered a new drug capable of stimulating innate immunity and showed that it is able of reducing tumor growth in a mouse model of GBM. We used ultrasmall iron oxide nanoparticles (USPIO) to track the migration of stimulated immune cells and showed that this drug related response can be detected with as little as 7 days of treatment. MRI tracking of immune cells using USPIO is a promising tool that can be easily translated into the clinical setting.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords